DP
Dilip Pawar
About Dilip Pawar
Data last updated:
Dilip Pawar was a Director at Adroit Biomed Limited (2010–2016), Director at Expergen Pharmaceuticals Private Limited (2011–2013) and Director at Akela Clinical Research Private Limited (from 2008), and held 1 more directorship. The companies operate in FMCG and Trading.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 Oct 2010 | 2009 | ₹53.89 Cr (FY 2024) | Active | |
| Director | 12 Feb 2011 | 2011 | ₹63,630 (FY 2020) | Active | |
| Director | 31 Jul 2008 | 2007 | Strike Off | ||
| Additional Director | 20 Mar 2008 | 2007 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dilip Pawar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dilip Pawar
Dilip Pawar was first appointed on 20 Mar 2008 as Additional Director at Icreat Consulting Private Limited. The most recent appointment on record is 12 Feb 2011 at Expergen Pharmaceuticals Private Limited.
Dilip Pawar held 4 earlier board appointments: Adroit Biomed Limited (Director, 19 Oct 2010 to 12 Nov 2016); Expergen Pharmaceuticals Private Limited (Director, 12 Feb 2011 to 05 Jan 2013); Akela Clinical Research Private Limited (Director, from 31 Jul 2008); Icreat Consulting Private Limited (Additional Director, from 20 Mar 2008).